Transaktionen anzeigen
Private Equity | Handel

FlyCap and the founder have sold Bio2You to INVL Baltic Sea Growth Fund

Latvia-based growth capital fund FlyCap has sold its 39% stake in Bio2You to INVL Baltic Sea Growth Fund. The remaining 61% of the shares was sold by the founder and CEO of the company. As a result of this transaction, INVL Baltic Sea Growth Fund now controls 100% of Bio2You.

Bio2You is a cosmetics manufacturer based in Latvia. The company offers private label and contract manufacturing services, as well as selling products under their own brand. It produces skin, body, hair and oral care products, and other bath and shower items (bath salts and bath bombs), as well as their own soap base. The brand has a particular focus on anti-aging products.

INVL Baltic Sea Growth Fund is a closed-end investment fund intended for professional investors and is one of the largest private equity investment funds in the Baltic region. It is focused on growth capital, buy-out, and buy-and-build investments.

Oaklins’ team in Latvia advised the sellers through all stages of this transaction.

DIENSTLEISTUNG
Verkauf
PARTEIEN

Sprechen Sie mit dem Deal Team

 Valērija  Lieģe

Valērija Lieģe

Partner

Riga, Lettland
Oaklins Baltics
 Reinholds R. Razums

Reinholds R. Razums

Senior Associate

Riga, Lettland
Oaklins Baltics
 Monta  Jaunarāja

Monta Jaunarāja

Associate

Riga, Lettland
Oaklins Baltics

Transaktionen

Matera has acquired a majority stake in Onidata Tecnologia
Private Equity | Finanzdienstleistungen | TMT

Matera has acquired a majority stake in Onidata Tecnologia

Matera has acquired a majority stake in Onidata Tecnologia.

Mehr erfahren
Frediani has been acquired by The Florence Group
Private Equity | Handel

Frediani has been acquired by The Florence Group

The Frediani family have sold Frediani S.r.l. to The Florence Group.

Mehr erfahren
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Private Equity | Gesundheitswesen

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Mehr erfahren